GTG 8.33% 1.1¢ genetic technologies limited

GTG Market Cap

  1. 101 Posts.
    OK, maybe I'm missing something .....

    The current Market Cap of GTG is $56M with a Share Price of $0.050.

    Kentgrove Capital Growth Fund are putting $24M into GTG. According to GTG's Quarterly Activities Report - 31 December 2014, GTG have $1.25M in Cash at the end of the December 2014 Quarter. Therefore, that's $25M in Cash. You would imagine that GTG has some value in their Assets in their business (e.g. Instruments, Equipment, etc).

    Does that mean that the difference (i.e. approximately $30M less their Asset value) is the value placed on GTG's IP, including BREVAGenplus?

    That sounds incredibly low to me when it used to have a Market Cap of well over $100M when it had a lot less Cash and when it had less access to distribution of BREVAGen / BREVAGenplus in the U.S.!

    Your thoughts?

    By the way, as of now the share price has just broken US$9.40 (up over 50% today)!
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
1.1¢
Change
-0.00(8.33%)
Mkt cap $30.52M
Open High Low Value Volume
1.2¢ 1.2¢ 1.1¢ $87.17K 7.763M

Buyers (Bids)

No. Vol. Price($)
1 397354 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 3004334 5
Last update - 16.10pm 22/10/2018 (20 minute delay) ?
(live)
Last
1.2¢
  Change
-0.00 ( 0.00 %)
Open High   Low Volume
1.2¢ 1.2¢   1.1¢ 3856131
Last updated 12.48pm 22/10/2018 (live) ?
GTG (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.